A potential role of NFIL3 in atherosclerosis

Guang-Gui Zeng,Jing Zhou,Wan-Li Jiang,Jiang Yu,Gui-Ying Nie,Jing Li,Shi-Qian Zhang,Chao-Ke Tang
DOI: https://doi.org/10.1016/j.cpcardiol.2023.102096
IF: 16.464
2023-09-23
Current Problems in Cardiology
Abstract:Nuclear factor interleukin-3(NFIL3), a proline‐ and acidic‐residue‐rich (PAR) bZIP transcription factor, is called the E4 binding protein 4 (E4BP4) as well, which is relevant to regulate the circadian rhythms and the viability of cells. More and more evidence has shown that NFIL3 is associated with different cardiovascular diseases. In recent years, it has been found that NFIL3 has significant functions in the progression of atherosclerosis via the regulation of inflammatory response, macrophage polarization, some immune cells and lipid metabolism. In this overview, we sum up the function of NFIL3 during the development of atherosclerosis and offer meaningful views how to treat cardiovascular disease related to atherosclerosis.
cardiac & cardiovascular systems
What problem does this paper attempt to address?